Revisão documental dos requisitos regulatórios internacionais para segurança de cosméticos com nanotecnologia
Vigilância Sanitária em Debate · 05.05.2026 · 1-20
DOI: 10.22239/2317-269x.02491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vigilância Sanitária em Debate, online erschienen am 05.05.2026. Verfasst von Glécia Virgolino da Silva Luz und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Cosmetics formulated with nanotechnology (1.0 x 10–⁹ m) have great market potential due to their effectiveness and consumer satisfaction.
Objective
To conduct a documentary review of international regulatory requirements related to the safety of cosmetics containing nanomaterials.
Method
A systematic documentary analysis was performed using official websites of eight regulatory agencies: the United States, European Union, Canada, Japan, Australia, China, India, and South Korea. The research was structured using the PICOT acronym. Documents were screened based on inclusion and exclusion criteria and evaluated by peer reviewers. Data extraction was conducted using REDCap® software and organized into thematic frameworks.
Results
Nine documents were included, with emphasis on those issued by the SCCS (EU), FDA (USA), ICCR, and MHLW (Japan). Regulatory convergence was observed in aspects such as the physicochemical characterization of nanomaterials (including size, morphology, purity, and stability) and the requirement for specific testing related to dermal irritation, inhalation toxicity, genotoxicity, and skin absorption. The analyzed documents highlight that nanomaterials may exhibit physicochemical properties, biological interactions, and toxicological effects distinct from the same ingredients on a conventional scale — with magnetic, optical, structural, electrical, and chemical differences that may impact product performance, safety, and efficacy.
Conclusions
There is no international regulatory consensus on mandatory criteria for the useof nanomaterials in cosmetics. Agencies recommend multiple validated tests, applied to different product batches, and emphasize the importance of detailed physicochemical characterization as well as dose–response assessment as essential requirements. The experience of more established jurisdictions can support the advancement of the Brazilian regulatory framework in this emerging field.
Zitieren
APA
Luz, G. V. D. S., Abreu, L. P. G. C., Posada, N. V. O. C., Abreu, R. G., Silva, G. C. V. D., Joanitti, G. A., & Carneiro, M. L. B. (2026). Revisão documental dos requisitos regulatórios internacionais para segurança de cosméticos com nanotecnologia. Vigilância Sanitária em Debate, 1-20. https://doi.org/10.22239/2317-269x.02491
Vancouver
Luz GVDS, Abreu LPGC, Posada NVOC, Abreu RG, Silva GCVD, Joanitti GA, et al. Revisão documental dos requisitos regulatórios internacionais para segurança de cosméticos com nanotecnologia. Vigilância Sanitária em Debate. 2026:1-20. doi:10.22239/2317-269x.02491
BibTeX
@article{Luz2026,
author = {Luz, Glécia Virgolino da Silva and Abreu, Ludmilla Pinto Guiotti Cintra and Posada, Nashira Vieira O’Reilly Cabral and Abreu, Ronaldo Gonçalves and Silva, Gleide Célia Virgolino da and Joanitti, Graziella Anselmo and Carneiro, Marcella Lemos Brettas},
title = {Revisão documental dos requisitos regulatórios internacionais para segurança de cosméticos com nanotecnologia},
journal = {Vigilância Sanitária em Debate},
year = {2026},
pages = {1--20},
doi = {10.22239/2317-269x.02491}
}
EUVIMED